Skip to content
The Nexus
DossierENTITY

Christopher Warlick

Coverage of Christopher Warlick in the Nexus archive.

Earliest in view: Jun 22 · 19:02 UTCMost recent: Jun 22 · 20:18 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJun 22 · 20:18 UTCWAFB BATON ROUGE
    Aging Untold: How to recognize when you’re stuck and grief becomes a barrier

    The article discusses prolonged grief and its impact on daily life, emphasizing the importance of seeking help. It also highlights the creation of a personal care manual to document preferences for caregiving and addresses the debate around PSA testing for prostate cancer. Additionally, it features a Tennessee goat ranch using animal therapy for healing.

  • HEALTHJun 22 · 20:18 UTCWBTV CHARLOTTE
    Aging Untold: How to recognize when you’re stuck and grief becomes a barrier

    The article discusses prolonged grief and strategies to address it, the importance of creating a personal care manual for aging adults, debates around PSA testing for prostate cancer, and the therapeutic benefits of animal interaction at a Tennessee goat ranch.

  • HEALTHJun 22 · 19:02 UTCWAFB BATON ROUGE
    PSA testing for prostate cancer: Understanding the debate

    PSA testing for prostate cancer detects elevated prostate-specific antigen levels but is controversial due to false positives and non-cancerous causes like enlarged prostates. Experts recommend men aged 55-69 and those at higher risk (family history, African American descent) discuss screening with healthcare providers, as early detection can improve outcomes for aggressive cancers.

  • HEALTHJun 22 · 19:02 UTCWBTV CHARLOTTE
    PSA testing for prostate cancer: Understanding the debate

    PSA testing for prostate cancer is controversial due to its potential for false positives and inability to distinguish between life-threatening and non-threatening cancers. Experts like Dr. Christopher Warlick highlight that elevated PSA levels can result from noncancerous conditions, and the United States Preventive Services Task Force recommends men aged 55-69 discuss screening with their providers, particularly those at higher risk such as African American men or those with family histories of prostate cancer.

  • HEALTHJun 22 · 19:02 UTCWSMV4 NASHVILLE
    PSA testing for prostate cancer: Understanding the debate

    PSA testing for prostate cancer is controversial due to its potential for false positives and non-cancerous causes of elevated PSA levels. Experts recommend men aged 55-69 discuss screening with providers, especially those at higher risk, such as African American men or those with family history. The test can detect life-threatening cancers early but may lead to unnecessary biopsies or treatment for slow-growing, non-threatening cancers.

Christopher Warlick · Dossier · The Nexus